$19.27
Today
as of Jul 22, 16:53 ET
Last 30 days
Recent Press Releases & News
Canaccord Genuity Initiates Relay Therapeutics at Buy With $29 Price Target
Relay Therapeutics Insider Sold Shares Worth $331,131, According to a Recent SEC Filing
Relay Therapeutics Insider Sold Shares Worth $943,736, According to a Recent SEC Filing
Overview
52-week range
$2.98
$17
100% of range
Avg surprise (last 3)
+2.4%
Avg reaction (last 2)
+0.7%
50% positive
Latest IV / EM
99%
EM ±22.6% · $19 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 5, 2026 | Mar/2026 | $-0.41 | $-0.35 | -17.1% | +10.9% | -0.7% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.43 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-0.41 | $-0.49 | +16.3% | — | — | earnings |
| Mon May 5, 2025 | Mar/2025 | $-0.46 | $-0.50 | +8.0% | — | +2.2% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.63 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.69 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.62 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.54 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.81 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | OTHER | -$0.41 | -$0.41 | 0.0% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3M | — | $0 | $677,000 | $8M | — | $0 | $0 |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-79M | — | $-80M | $-77M | $-85M | — | $-96M | $-101M |
| Net income | $-73M | — | $-74M | $-70M | $-77M | — | $-88M | $-92M |
| EPS (diluted) | $-0.41 | — | $-0.43 | $-0.41 | $-0.46 | — | $-0.63 | $-0.69 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $205M | $84M | $92M | $114M | $94M | $124M | $152M | $134M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $658M | $578M | $624M | $680M | $740M | $809M | $865M | $704M |
| Total assets | $700M | $621M | $670M | $729M | $799M | $871M | $930M | $773M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $57M | $54M | $62M | $63M | $78M | $94M | $91M | $91M |
| Total equity | $642M | $567M | $608M | $666M | $721M | $778M | $839M | $682M |